1. Home
  2. AYTU vs JVA Comparison

AYTU vs JVA Comparison

Compare AYTU & JVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AYTU
  • JVA
  • Stock Information
  • Founded
  • AYTU N/A
  • JVA 1971
  • Country
  • AYTU United States
  • JVA United States
  • Employees
  • AYTU N/A
  • JVA N/A
  • Industry
  • AYTU Biotechnology: Pharmaceutical Preparations
  • JVA Packaged Foods
  • Sector
  • AYTU Health Care
  • JVA Consumer Staples
  • Exchange
  • AYTU Nasdaq
  • JVA Nasdaq
  • Market Cap
  • AYTU 9.6M
  • JVA 19.5M
  • IPO Year
  • AYTU N/A
  • JVA 2005
  • Fundamental
  • Price
  • AYTU $2.39
  • JVA $4.40
  • Analyst Decision
  • AYTU Strong Buy
  • JVA
  • Analyst Count
  • AYTU 2
  • JVA 0
  • Target Price
  • AYTU $10.00
  • JVA N/A
  • AVG Volume (30 Days)
  • AYTU 669.1K
  • JVA 242.2K
  • Earning Date
  • AYTU 05-14-2025
  • JVA 06-13-2025
  • Dividend Yield
  • AYTU N/A
  • JVA N/A
  • EPS Growth
  • AYTU N/A
  • JVA 856.08
  • EPS
  • AYTU N/A
  • JVA 0.65
  • Revenue
  • AYTU $81,659,000.00
  • JVA $84,651,329.00
  • Revenue This Year
  • AYTU N/A
  • JVA N/A
  • Revenue Next Year
  • AYTU $8.68
  • JVA N/A
  • P/E Ratio
  • AYTU $13.06
  • JVA $6.89
  • Revenue Growth
  • AYTU 0.41
  • JVA 15.86
  • 52 Week Low
  • AYTU $0.95
  • JVA $1.50
  • 52 Week High
  • AYTU $2.96
  • JVA $9.93
  • Technical
  • Relative Strength Index (RSI)
  • AYTU 70.58
  • JVA 56.01
  • Support Level
  • AYTU $2.04
  • JVA $4.13
  • Resistance Level
  • AYTU $2.40
  • JVA $4.45
  • Average True Range (ATR)
  • AYTU 0.14
  • JVA 0.40
  • MACD
  • AYTU 0.02
  • JVA -0.01
  • Stochastic Oscillator
  • AYTU 87.27
  • JVA 41.67

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.

About JVA Coffee Holding Co. Inc.

Coffee Holding Co Inc is engaged in wholesale coffee operations, including manufacturing, roasting, packaging, marketing, and distributing roasted and blended coffees for privately labeled accounts and its brands, and it sells green coffee. The Company also manufactures and sells coffee roasters. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada, and certain Asian countries. The group's services are Custom Blending, Food Service Programs, and Private Label Services.

Share on Social Networks: